Using biomarkers to guide heart failure management.

about

Influencing factors of NT-proBNP level inheart failure patients with different cardiacfunctions and correlation with prognosis.

P2860

Q55400966-AA3F6896-E2C5-429D-B931-413C677A43A6

P2860

Using biomarkers to guide heart failure management.

Item

http://www.wikidata.org/entity/Q38613842

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Using biomarkers to guide heart failure management.

@en

type

Item

label

Using biomarkers to guide heart failure management.

@en

prefLabel

Using biomarkers to guide heart failure management.

@en

P1476

Using biomarkers to guide heart failure management.

@en

P2093

Alan S Maisel

http://www.w3.org/2001/XMLSchema#string

Kay-Won Chang

http://www.w3.org/2001/XMLSchema#string

Sean Mojaver

http://www.w3.org/2001/XMLSchema#string

Sutton Fox

http://www.w3.org/2001/XMLSchema#string

P2860

2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

2013 ACCF/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines

Angiotensin-neprilysin inhibition versus enalapril in heart failure

Troponin elevation in patients with heart failure: on behalf of the third Universal Definition of Myocardial Infarction Global Task Force: Heart Failure Section

2016 ACC/AHA/HFSA Focused Update on New Pharmacological Therapy for Heart Failure: An Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on

Serial sampling of ST2 predicts 90-day mortality following destabilized heart failure

Characteristics of the novel interleukin family biomarker ST2 in patients with acute heart failure

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.

State of the art of BNP and NT-proBNP immunoassays: the CardioOrmoCheck study.

Soluble ST2 in ambulatory patients with heart failure: Association with functional capacity and long-term outcomes.

P304

1-13

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/14779072.2017.1366312

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28830266

http://www.w3.org/2001/XMLSchema#string

P921

heart failure

biomarker

Using biomarkers to guide heart failure management.

about

P2860

P2860

Using biomarkers to guide heart failure management.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P577

P698

P921